News

Abbott has announced that Xience Prime everolimus eluting coronary stent system and the Xience V everolimus eluting coronary stent system have received additional new CE Markings covering the

Cevec Pharmaceuticals (Cevec) has reported the closing of a E4m financing round that is aimed to finance the growth of human CAP technology. Creathor Venture Fonds and NRW.BANK

Express Scripts and Greatwater Software have entered into an agreement that will enable patients to review options for reducing prescription costs when checking in for appointments at their

Aflex Hose has unveiled Corroline, a flexible hose developed to stand up to the toughest chemical and process applications. Corroline is built around a patented PTFE (polytetrafluoroethylene) hose

Medpace has entered into a purchase agreement to acquire Pharma Brains , an oncology focused CRO based in Basel, Switzerland. Pharma Brains is expected to provide Medpace with

Novavax has made a poster presentation on the “Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine in Healthy Adults” at the 47th annual

Cobra Biomanufacturing reported that the current Good Manufacturing Practice (cGMP) production of Scancell’s SCIB1 DNA vaccine has been successfully completed ahead of the planned clinical trials that are

According to results of an intent-to-treat (ITT) analysis announced by Vertex Pharmaceuticals, more than 80% of hepatitis C patients in each arm of the phase 2 Study C208

Valeant Pharmaceuticals (Valeant) has reported a total revenue of $220.3m for the third quarter of 2009, an increase of 31% compared to $168.4m in the third quarter of